HEALTHCARE & MEDICARE
-
Novartis acquires rare kidney disease drugs prepared in stage 3 through $800 million acquisition
Novartis has made kidney disease a priority area, and now it is using a deal to get Regulus Therapeutics, a…
Read More » -
Medcity femfwd: Collecting data on improving maternal health
Welcome back to another episode of MedCity Femfwd, a podcast dedicated to discussing breakthroughs and challenges in women’s health. In…
Read More » -
Success in Chaos: Building Resilient Systems in Unpredictable Future
Chaos has always been a part of healthcare. In a system where every decision has life-changing consequences, it is not…
Read More » -
Advisor to self-sufficient employers: Share your experiences and opinions in this new survey
Wondering what your peers see the biggest shift in healthcare benefits – from increasing demand for GLP-1 to AI-driven decision…
Read More » -
Novo Nordisk's GLP-1 partnership with Hims & Hers
Pharmaceutical company Novo Nordisk will partner with direct-to-consumer telemedicine company Hims & Hers to offer discounts to Novo Nordisk-made GLP-1…
Read More » -
Hospital leaders share how they balance finance, innovation and patient care
In the changing market and the shallower pockets, health system leaders are limiting. Hospitals across the country are balancing new…
Read More » -
FDA Approves Abeona Gene Therapy for Rare, Hereditary Skin Disease Treatment
Patients with the most severe hereditary disease suffer from skin, are susceptible to injury, and some never fully heal. The…
Read More » -
AIQ Command: New Competitive Paradigm for Biopharmaceuticals
Artificial intelligence is redrawing the possible boundaries in drug development. For decades, the pharmaceutical business model has been based on…
Read More » -
Webinar: How FinTech Accelerates Growth in Early Life Sciences Companies
The journey of healthcare startups is not for cowardice. Browse the path to showcase proof of concept, find stakeholders to…
Read More » -
Bloom
Jeff Goldsmith A 40-year growth legend is about to end UnitedHealth Group reported its first quarter 2025 earnings after closing…
Read More »